US 10246709
Targeting ligands for therapeutic compounds
granted A61KA61K31/713A61K47/549
Quick answer
US patent 10246709 (Targeting ligands for therapeutic compounds) held by Arrowhead Pharmaceuticals, Inc. expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/713, A61K47/549, A61P, A61P43/00